These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 30736475)

  • 81. Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?
    Cidon EU; Alonso P; Masters B
    Clin Med Insights Oncol; 2016; 10(Suppl 1):41-55. PubMed ID: 27147901
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Biomarkers in precision therapy in colorectal cancer.
    Reimers MS; Zeestraten EC; Kuppen PJ; Liefers GJ; van de Velde CJ
    Gastroenterol Rep (Oxf); 2013 Nov; 1(3):166-83. PubMed ID: 24759962
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status.
    Lee JK; Chan AT
    Curr Colorectal Cancer Rep; 2011 Jun; 7(2):136-144. PubMed ID: 21572547
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Novel biomarkers for the diagnosis and prognosis of colorectal cancer.
    Oh HH; Joo YE
    Intest Res; 2020 Apr; 18(2):168-183. PubMed ID: 31766836
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of CTLA4 and pSTAT3 Immunostaining in Prognosis and Treatment of the Colorectal Carcinoma.
    Mohamed Allam D; Kasem H; Hegazy A; Mahmoud SF
    Iran J Pathol; 2024; 19(1):89-102. PubMed ID: 38864078
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Biomarker-directed Targeted Therapy in Colorectal Cancer.
    Carethers JM
    J Dig Cancer Rep; 2015 Jun; 3(1):5-10. PubMed ID: 26609516
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Circulating microRNAs as Promising Biomarkers in Colorectal Cancer.
    Rapado-González Ó; Álvarez-Castro A; López-López R; Iglesias-Canle J; Suárez-Cunqueiro MM; Muinelo-Romay L
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252648
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges.
    Koncina E; Haan S; Rauh S; Letellier E
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32019056
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Role of circulating free DNA in colorectal cancer.
    Matikas A; Voutsina A; Trypaki M; Georgoulias V
    World J Gastrointest Oncol; 2016 Dec; 8(12):810-818. PubMed ID: 28035251
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives.
    Battaglin F; Puccini A; Naseem M; Schirripa M; Berger MD; Tokunaga R; McSkane M; Khoukaz T; Soni S; Zhang W; Lenz HJ
    J Cancer Metastasis Treat; 2018; 4(3):. PubMed ID: 34532592
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical application of genetics in management of colorectal cancer.
    Kim ER; Kim YH
    Intest Res; 2014 Jul; 12(3):184-93. PubMed ID: 25349592
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer.
    Jiang H; Zhou S; Li G
    Front Pharmacol; 2023; 14():1189799. PubMed ID: 37719843
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of dietary components on miRNA and colorectal carcinogenesis.
    Fadaka AO; Ojo BA; Adewale OB; Esho T; Pretorius A
    Cancer Cell Int; 2018; 18():130. PubMed ID: 30202241
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment.
    Verdaguer H; Saurí T; Macarulla T
    J Gastrointest Oncol; 2017 Jun; 8(3):405-417. PubMed ID: 28736628
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Update on systemic therapy for colorectal cancer: biologics take sides.
    Gbolahan O; O'Neil B
    Transl Gastroenterol Hepatol; 2019; 4():9. PubMed ID: 30976712
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Colorectal Cancer and Bone Tissue: Fantastic Relations and Where to Find Them.
    Gigante I; Tutino V; De Nunzio V; Notarnicola M
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722068
    [TBL] [Abstract][Full Text] [Related]  

  • 97. What Is Known about Theragnostic Strategies in Colorectal Cancer.
    Parisi A; Porzio G; Pulcini F; Cannita K; Ficorella C; Mattei V; Delle Monache S
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33535557
    [TBL] [Abstract][Full Text] [Related]  

  • 98. miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer.
    Hon KW; Abu N; Ab Mutalib NS; Jamal R
    Front Pharmacol; 2018; 9():846. PubMed ID: 30127741
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Precision medicine for adjuvant chemotherapy of resected colorectal cancer.
    Miyamoto Y; Hiyoshi Y; Sawayama H; Tokunaga R; Baba H
    Ann Gastroenterol Surg; 2020 Nov; 4(6):635-645. PubMed ID: 33319153
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer.
    Dazio G; Epistolio S; Frattini M; Saletti P
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.